The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Author： Louie Samuel   Zeki Amir A   Schivo Michael   Chan Andrew L   Yoneda Ken Y   Avdalovic Mark   Morrissey Brian M   Albertson Timothy E  

Publisher： Informa Healthcare

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.6, Iss.2, 2013-03, pp. : 197-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease

By Belvisi Maria G   Hele David J   Birrell Mark A  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 265-285

Informa Healthcare

Access to resources Recommend Favorite

Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-&kgr;B

By  

Current Medicinal Chemistry, Vol. 16, Iss. 7, 2009-03 ,pp. : 867-883

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 16, Iss. 32, 2010-11 ,pp. : 3554-3573

Bentham Science Publishers

Access to resources Recommend Favorite

Asthma COPD Overlap Syndrome: An Approach to A Real -World Endotype in Obstructive Lung Disease?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6273-6282

Bentham Science Publishers

Access to resources Recommend Favorite